TY - JOUR
T1 - Hospital surveillance of respiratory viruses during the COVID-19 pandemic and beyond
T2 - contribution to the WHO mosaic framework, Israel, 2020 to 2023
AU - Israeli Respiratory Viruses Hospital Laboratory Network (IRVHLN)
AU - Gur-Arie, Lea
AU - Stein, Michal
AU - Sefty, Hanna
AU - Fratty, Ilana S.
AU - Nemet, Ital
AU - Kliker, Limor
AU - Atari, Nofar
AU - Zuckerman, Neta S.
AU - Rosenberg, Alina
AU - Ivgi, Heftziba
AU - Golan-Shany, Orit
AU - Sorek, Nadav
AU - Schwartz-Harari, Orna
AU - Bromberg, Michal
AU - Keinan-Boker, Lital
AU - Mandelboim, Michal
AU - Glatman-Freedman, Aharona
AU - Peretz, Avi
AU - Ben-Zvi, Haim
AU - Rechnitzer, Hagai
AU - Roif-Kaminsky, Diana
AU - Schindler, Yehudit
AU - Szwarcwort-Cohen, Moran
AU - Halutz, Ora
AU - Wolf, Dana G.
AU - Shemer-Avni, Yonat
AU - Keren-Naus, Ayelet
AU - Chaim, Adina Bar
AU - Freimann, Sarit
AU - Strauss, Merav
AU - Amram, Hila Ben
AU - Sztejrenszus, Saar Yosef
AU - Shaked-Mishan, Pninit
AU - Lellouche, Jonathan
AU - Arielly, Haya
AU - Bardenstein, Rita
AU - Assi, Camellia Khoury
AU - Jabbour, Adel
AU - Lipinsky, Dafna
N1 - Publisher Copyright:
© 2024 European Centre for Disease Prevention and Control (ECDC). All rights reserved.
PY - 2024/8/8
Y1 - 2024/8/8
N2 - Background: A new respiratory virus surveillance platform, based on nationwide hospital laboratory data, was established in Israel during the COVID-19 pandemic. Aim: We aimed to evaluate the performance of this platform with respect to the detection of influenza and respiratory syncytial virus (RSV) from week 36 in 2020 to week 15 in 2023, and how it fits with the World Health Organization (WHO) mosaic surveillance framework. Methods: Data of respiratory samples from hospitalised patients sent for laboratory confirmation of influenza virus or RSV from 25 general hospital laboratories nationwide were collected. We analysed the weekly number and percentage of samples positive for influenza virus or RSV vis-à-vis SARS-CoV-2 activity and compared data from the new surveillance platform with existing surveillance platforms. Using data in the new surveillance platform, we analysed early stages of a 2021 out-of-season RSV outbreak and evaluated the capabilities of the new surveillance system with respect to objectives and domains of the WHO mosaic framework. Results: The new hospital-laboratory surveillance platform captured the activity of influenza virus and RSV, provided crucial data when outpatient sentinel surveillance was not operational and supported an out-of-season RSV outbreak investigation. The new surveillance platform fulfilled important objectives in all three domains of the mosaic framework and could serve for gathering additional information to fulfil more domain objectives. Conclusion: The new hospital laboratory surveillance platform provided essential data during the COVID-19 pandemic and beyond, fulfilled important domain objectives of the mosaic framework and could be adapted for the surveillance of other viruses.
AB - Background: A new respiratory virus surveillance platform, based on nationwide hospital laboratory data, was established in Israel during the COVID-19 pandemic. Aim: We aimed to evaluate the performance of this platform with respect to the detection of influenza and respiratory syncytial virus (RSV) from week 36 in 2020 to week 15 in 2023, and how it fits with the World Health Organization (WHO) mosaic surveillance framework. Methods: Data of respiratory samples from hospitalised patients sent for laboratory confirmation of influenza virus or RSV from 25 general hospital laboratories nationwide were collected. We analysed the weekly number and percentage of samples positive for influenza virus or RSV vis-à-vis SARS-CoV-2 activity and compared data from the new surveillance platform with existing surveillance platforms. Using data in the new surveillance platform, we analysed early stages of a 2021 out-of-season RSV outbreak and evaluated the capabilities of the new surveillance system with respect to objectives and domains of the WHO mosaic framework. Results: The new hospital-laboratory surveillance platform captured the activity of influenza virus and RSV, provided crucial data when outpatient sentinel surveillance was not operational and supported an out-of-season RSV outbreak investigation. The new surveillance platform fulfilled important objectives in all three domains of the mosaic framework and could serve for gathering additional information to fulfil more domain objectives. Conclusion: The new hospital laboratory surveillance platform provided essential data during the COVID-19 pandemic and beyond, fulfilled important domain objectives of the mosaic framework and could be adapted for the surveillance of other viruses.
UR - http://www.scopus.com/inward/record.url?scp=85201035740&partnerID=8YFLogxK
U2 - 10.2807/1560-7917.ES.2024.29.32.2300634
DO - 10.2807/1560-7917.ES.2024.29.32.2300634
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 39119719
AN - SCOPUS:85201035740
SN - 1025-496X
VL - 29
JO - Eurosurveillance
JF - Eurosurveillance
IS - 32
M1 - 2300634
ER -